{"id":289399,"date":"2021-07-02T07:58:01","date_gmt":"2021-07-02T04:58:01","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/early-data-shows-johnson-johnson-vaccine-works-against-delta-variant\/"},"modified":"2021-07-02T07:58:01","modified_gmt":"2021-07-02T04:58:01","slug":"early-data-shows-johnson-johnson-vaccine-works-against-delta-variant","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/early-data-shows-johnson-johnson-vaccine-works-against-delta-variant\/","title":{"rendered":"#Early data shows Johnson & Johnson vaccine works against Delta variant"},"content":{"rendered":"

“#Early data shows Johnson & Johnson vaccine works against Delta variant<\/strong>”<\/p>\n

\n

Johnson & Johnson said late Thursday that preliminary data shows its single-shot vaccine is effective against the fast-spreading Delta variant of COVID-19 that was first discovered in India.<\/p>\n

In a statement<\/a>, the New Jersey-based company said that its vaccine generated an immune response against the variant that lasted at least eight months. J&J added that its vaccine caused more antibody activity against the Delta variant than against the Beta variant, which was first located in South Africa, though the dose worked against all so-called \u201cvariants of concern.\u201d<\/p>\n

The company said the data came from two small sub-studies that were offshoots of its original vaccine trial. Both studies, which examined vaccine recipients\u2019 blood, had been submitted for publication. <\/p>\n

\u201cToday\u2019s newly announced studies reinforce the ability of the Johnson & Johnson COVID-19 vaccine to help protect the health of people globally,\u201d said J&J Chief Scientific Officer Dr. Paul Stoffels in a statement. \u201cWe believe that our vaccine offers durable protection against COVID-19 and elicits neutralizing activity against the Delta variant. This adds to the robust body of clinical data supporting our single-shot vaccine\u2019s ability to protect against multiple variants of concern.\u201d<\/p>\n

\u201cCurrent data for the eight months studied so far show that the single-shot Johnson & Johnson COVID-19 vaccine generates a strong neutralizing antibody response that does not wane; rather, we observe an improvement over time,\u201d added Dr. Mathai Mammen, the head of research and development for Johnson & Johnson\u2019s pharmaceutical division. \u201cIn addition, we observe a persistent and particularly robust, durable cellular immune response. With each new dataset, we build on our solid foundation of evidence that our single-shot COVID-19 vaccine plays a critical role in ending the pandemic, which continues to evolve and pose new challenges to global health.\u201d<\/p>\n

\"Syringes
Syringes filled with the Johnson & Johnson vaccine at a mobile vaccination site in Miami.<\/figcaption>
AP<\/span><\/figcaption><\/figure>\n

The announcement follows an announcement earlier this week by Moderna that its mRNA vaccine had produced antibodies against several coronavirus variants, including the Delta strain, in a lab study. A separate study published in the journal Nature<\/a> suggested mRNA vaccines produced by Moderna and Pfizer could provide \u201cpersistent\u201d protection against COVID-19 for years \u2014 provided the virus doesn\u2019t mutate too much beyond its current forms.<\/p>\n

On Wednesday, Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky said fully vaccinated Americans are \u201cquite protected from the variants that we have circulating here in the United States\u201d and reiterated that those people do not need to wear a mask.<\/p>\n

That came on the heels of a recommendation by Los Angeles County health officials for people to resume wearing masks in indoor public spaces, regardless of their vaccination status, due to an increase in cases blamed on the variant.<\/p>\n

Walensky also told NBC\u2019s \u201cToday\u201d show that Americans who received the J&J vaccine likely don\u2019t need to go back for a booster shot, a statement supported by the preliminary data announced Thursday. <\/p>\n

\u201cWe have every reason to believe, based on how J&J is performing with other variants of concern \u2013 and that is quite well \u2013 and how its sister vaccine, AstraZeneca, has performed against the Delta variant in other countries \u2026 people are agreeing that they anticipate that the J&J will perform well against the Delta variant, as it has so far against other variants circulating in the United States,\u201d she said.\n <\/p><\/div>\n

If you liked the article, do not forget to share it with your friends. Follow us on\u00a0Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n

\n

For forums sites go to Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

\n

If you want to read more News<\/a> articles, you can visit our News category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

“#Early data shows Johnson & Johnson vaccine works against Delta variant” Johnson & Johnson said late Thursday that preliminary data shows its single-shot vaccine is effective against the fast-spreading Delta variant of COVID-19 that was first discovered in India. In a statement, the New Jersey-based company said that its vaccine generated an immune response against…<\/p>\n","protected":false},"author":1,"featured_media":289400,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/nypost.com\/wp-content\/uploads\/sites\/2\/2021\/07\/jj-vaccine-delta-effective-index.jpg?quality=90&strip=all&w=1200","fifu_image_alt":"","footnotes":""},"categories":[70897],"tags":[110930,71464,1545,82862,71061],"class_list":["post-289399","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-7-2-21","tag-cdc","tag-coronavirus","tag-covid-vaccine","tag-johnson-johnson"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/289399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=289399"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/289399\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/289400"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=289399"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=289399"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=289399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}